SMARCB1 and epithelioid sarcoma: Numerous studies have revealed decreases in SMARCB1 expression or inactivation of SMARCB1 in various cancers, such as malignant rhabdoid tumours,12 familial schwannomatosis13 and epithelioid sarcomas.14